Investment Summary

Ballast Point Ventures Exits Intelligent Retinal Imaging Systems

On July 31, 2025, Topcon Healthcare invested in medical products company Intelligent Retinal Imaging Systems from Ballast Point Ventures

Investment Highlights
  • This is Topcon Healthcare’s 2nd transaction in the Medical Products sector.
  • This is Topcon Healthcare’s 1st transaction in the United States.
  • This is Topcon Healthcare’s 1st transaction in Florida.

Investment Summary

Date 2025-07-31
Target Intelligent Retinal Imaging Systems
Sector Medical Products
Investor(s) Topcon Healthcare
Sellers(s) Ballast Point Ventures
Deal Type Add-on Acquisition

Target

Intelligent Retinal Imaging Systems

Pensacola, Florida, United States
Intelligent Retinal Imaging Systems provides an end-to-end, FDA-cleared telemedicine platform that allows for early detection of diabetic eye disease in the primary care setting. Intelligent Retinal Imaging Systems was founded in 2011 and is based in Pensacola, Florida.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Topcon Healthcare

Oakland, New Jersey, United States

Category Company
Sector Information Technology
DESCRIPTION

Topcon Healthcare empowers providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever-changing landscape of the healthcare industry. It offers the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management, safe distancing, and ground-breaking remote diagnostic technology. Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare, and physician shortages.


DEAL STATS #
Overall 3 of 3
Sector: Medical Products M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: Florida M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-05-02 RetInSight

Vienna, Austria

RetInSight’s AI algorithms analyze optical coherence tomography (OCT) images captured in routine clinical care to detect and monitor major retinal diseases – geographic atrophy, neovascular age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. RetInSight was formed in 2020 and is based in Vienna, Austria.

Buy -

Seller(S) 1

SELLER

Ballast Point Ventures

Tampa, Florida, United States

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 2001
PE ASSETS 550M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Ballast Point Ventures is a private investment firm that targets growth businesses located in the South US. Ballast Point looks to commit $5 to $15 million of equity capital per transaction and looks for businesses in markets with annual revenues of at least $100 million. Sectors of interest include healthcare, information technology (IT), financial services, communications, business services, and consumer products/services. Ballast Point Ventures was formed in 2001 and is based in Tampa, Florida.


DEAL STATS #
Overall 34 of 34
Sector: Medical Products M&A 3 of 3
Type: Add-on Acquisition M&A Deals 14 of 14
State: Florida M&A 10 of 10
Country: United States M&A 34 of 34
Year: 2025 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-07-08 Abacode

Tampa, Florida, United States

Abacode is a managed security services provider with an emphasis on Governance, Risk, and Compliance readiness services and a suite of related cybersecurity professional services. Abacode was founded in 2014 and is based in Tampa, Florida.

Sell -